文献速递皮肤肿瘤

患者与皮肤科医生对增强智能用于黑色素瘤筛查的看法:一项前瞻性研究

Patient and dermatologists' perspectives on augmented intelligence for melanoma screening: A prospective study.
PubMed 文献 · J Eur Acad Dermatol Venereol · 2024-02-27

在巴塞尔大学医院开展的前瞻性比较队列研究,纳入205例黑色素瘤高危患者和8名皮肤科医生,评估人工、人工智能及增强智能筛查后的观点。多数患者认为AI可提高诊断性能(95.5%),83.4%偏好增强智能筛查;增强智能带来的安全感评分显著高于单独AI或医生筛查。皮肤科医生对AI结果信任度高,但在风险判断分歧时仅1.5%更信任CNN良性分类而非个人恶性怀疑。

要点

  • 患者偏好增强智能联合3D全身摄影进行黑色素瘤筛查,安全感评分更高。
  • 皮肤科医生对AI结果信任度高,但风险判断分歧时仍主要依赖自身决策。
  • 初学者皮肤科医生比专家更认为AI有助于临床工作。

核心结论

  • 患者已偏好增强智能联合3D全身摄影进行黑色素瘤识别,而皮肤科医生尽管对AI结果高度信任,仍主要依赖自身决策。

研究设计与样本

  • 前瞻性比较队列研究,在巴塞尔大学医院纳入205例黑色素瘤高危患者(已切除或晚期疾病)和8名皮肤科医生。
  • 患者接受皮肤科医生筛查及后续2D和3D全身摄影, suspicious及所有≥3 mm的黑素细胞皮损用数字皮肤镜成像并由卷积神经网络分类。
  • 根据医生黑色素瘤怀疑、研究定义的CNN风险评分升高和/或增强智能的黑色素瘤怀疑进行切除,随后用问卷调查研究患者和医生的体验。

主要发现

  • 大多数患者认为AI可提高诊断性能(95.5%,n=192/201)。
  • 83.4%的患者偏好基于增强智能的皮肤癌筛查,而非单独AI或医生检查(3D-TBP:61.3%;2D-TBP:22.1%,n=199)。
  • 增强智能引发的安全感评分显著高于单独AI(平均SSS:9.5 vs. 7.7,p<0.0001)或单独医生筛查(平均SSS:9.5 vs. 9.1,p=0.001)。
  • 大多数皮肤科医生对AI检查结果表示高度信任(3D-TBP:90.2%;2D-TBP:96.1%,n=205)。
  • 68.3%的检查中皮肤科医生认为额外AI评估提高了诊断准确性(n=140/205);初学者(<2年皮肤镜经验;61.8%,n=94/152)比专家(>5年皮肤镜经验;20.9%,n=9/43)更认为AI促进了临床工作。

临床怎么用

  • 增强智能联合3D全身摄影可提高患者筛查安全感并受多数患者偏好。
  • 皮肤科医生可将AI作为辅助工具,但风险判断分歧时仍应坚持自身恶性怀疑。
  • 对初学者皮肤科医生,AI评估可能更有助于提升诊断信心和工作效率。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Artificial intelligence (AI) shows promising potential to enhance human decision-making as synergistic augmented intelligence (AuI), but requires critical evaluation for skin cancer screening in a real-world setting. OBJECTIVES: To investigate the perspectives of patients and dermatologists after skin cancer screening by human, artificial and augmented intelligence. METHODS: A prospective comparative cohort study conducted at the University Hospital Basel included 205 patients (at high-risk of developing melanoma, with resected or advanced disease) and 8 dermatologists. Patients underwent skin cancer screening by a dermatologist with subsequent 2D and 3D total-body photography (TBP). Any suspicious and all melanocytic skin lesions ≥3 mm were imaged with digital dermoscopes and classified by corresponding convolutional neural networks (CNNs). Excisions were performed based on dermatologist's melanoma suspicion, study-defined elevated CNN risk-scores and/or melanoma suspicion by AuI. Subsequently, all patients and dermatologists were surveyed about their experience using questionnaires, including quantification of patient's safety sense following different examinations (subjective safety score (SSS): 0-10). RESULTS: Most patients believed AI could improve diagnostic performance (95.5%, n = 192/201). In total, 83.4% preferred AuI-based skin cancer screening compared to examination by AI or dermatologist alone (3D-TBP: 61.3%; 2D-TBP: 22.1%, n = 199). Regarding SSS, AuI induced a significantly higher feeling of safety than AI (mean-SSS (mSSS): 9.5 vs. 7.7, p < 0.0001) or dermatologist screening alone (mSSS: 9.5 vs. 9.1, p = 0.001). Most dermatologists expressed high trust in AI examination results (3D-TBP: 90.2%; 2D-TBP: 96.1%, n = 205). In 68.3% of the examinations, dermatologists felt that diagnostic accuracy improved through additional AI-assessment (n = 140/205). Especially beginners (<2 years' dermoscopic experience; 61.8%, n = 94/152) felt AI facilitated their clinical work compared to experts (>5 years' dermoscopic experience; 20.9%, n = 9/43). Contrarily, in divergent risk assessments, only 1.5% of dermatologists trusted a benign CNN-classification more than personal malignancy suspicion (n = 3/205). CONCLUSIONS: While patients already prefer AuI with 3D-TBP for melanoma recognition, dermatologists continue to rely largely on their own decision-making despite high confidence in AI-results. TRIAL REGISTRATION: ClinicalTrials.gov (NCT04605822).

来源:J Eur Acad Dermatol Venereol,查看原文。版权归原作者所有。

引用

  1. Goessinger EV, Niederfeilner JC, Cerminara S, et al. Patient and dermatologists' perspectives on augmented intelligence for melanoma screening: A prospective study. J Eur Acad Dermatol Venereol. 2024. PMID: 38411348. doi:10.1111/jdv.19905

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。